Search

everythinglearnresearchcommunity

for

Search:↓

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

A new method was created to measure metformin in hair, showing potential for monitoring treatment and medical investigations.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The book provides comprehensive treatment strategies for female hair loss.

RF-based therapies might help treat hair loss.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.

Using developmental signaling pathways could improve adult wound healing by mimicking scarless embryonic healing.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Laser and cell treatments effectively help hair regrowth in people with focal alopecia.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

The treatments helped the girl's hair grow back, but more research is needed for different types of hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Oral minoxidil may help hair regrowth in female cancer survivors.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

More personalized and effective treatments for androgenetic alopecia are needed.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.